SAN DIEGO, CA--(Marketwired - July 21, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that the Company was featured in a Money Show article about its leading role in the world's fastest growing industry: cannabis. The Company also announced that it is sponsoring The San Francisco Money Show's Cannabis Investing Symposium where Medical Marijuana, Inc. CEO Dr. Stuart Titus will speak to investors about current global industry trends and how the Company's diversified portfolio of cannabis companies and brands are capitalizing on the current cannabis revolution.
According to the MoneyShow.com article, "Medical Marijuana Making Global Waves," Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the world, is structured in a "way that can create strategic value for shareholders."
The article also mentioned the Company's recent significant progress in Latin America, including recent import permits received in Brazil, Mexico and Paraguay, stating: "The diversity of Medical Marijuana, Inc.'s subsidiaries and investments has enabled the company to see significant year-over-year revenue growth. These assets also strengthen Medical Marijuana, Inc.'s balance sheet and allow the company to find strategic ways to create value."
Medical Marijuana, Inc. will be sponsoring and attending The Cannabis Investing Symposium at the 35th annual Money Show San Francisco 2016 from August 23-25 and the Company's CEO Dr. Stuart Titus also present to investors at the Symposium. The Cannabis Investing Symposium will specifically focus on helping investors identify and engage with cannabis companies that represent profitable investments.
"I'm honored that Medical Marijuana, Inc. was asked to be one of the only cannabis companies featured at Money Show's Cannabis Investing Symposium, which is providing investors with the information they need to get involved in this fast-growing industry with limitless opportunities," Titus said. "This is a premiere opportunity for us to share our Company's story and raise awareness of the newest multibillion-dollar U.S. industry that is helping people who suffer with debilitating conditions across the globe."
Representatives from Medical Marijuana, Inc.'s Investor Relations team will be available at the Company's booth #315 for sit-down meetings and questions.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.